Intestinal permeability and function in dogs with small intestinal bacterial overgrowth.
Small intestinal bacterial overgrowth (SIBO) has been reported to occur commonly in dogs with signs of chronic intestinal disease. There are usually few intestinal histological changes, and it is uncertain to what extent bacteria cause mucosal damage. The aim of this study was to apply a differential sugar absorption test for intestinal permeability and function to the objective assessment of intestinal damage in dogs with SIBO. Studies were performed on 63 dogs with signs of chronic small and, or, large bowel disease, in which SIBO (greater than 10(5) total or greater than 10(4) anaerobic colony forming units/ml) was diagnosed by quantitative culture of duodenal juice obtained endoscopically. None of the dogs had evidence of intestinal pathogens, parasites, systemic disease or pancreatic insufficiency. differential sugar absorption was performed by determining the ratios of urinary recoveries of lactulose/rhamnose (L/R ratio, which reflects permeability) and D-xylose/3-O-methylglucose (X/G ratio, which reflects intestinal absorptive function) following oral administration. Dogs with SIBO comprised 28 different breeds, including 13 German shepherd dogs. SIBO was aerobic in 18/63 dogs (29 per cent), and anaerobic in 45/63 (71 per cent). Histological examination of duodenal biopsies showed no abnormalities in 75 per cent, and mild to moderate lymphocytic infiltrates in 25 per cent of the dogs. The L/R ratio was increased (greater than 0.12) in 52 per cent, and the X/G ratio reduced (less than 0.60) in 33 per cent of the dogs. Differential sugar absorption was repeated in 11 dogs after their four weeks of oral antibiotic therapy. The L/R ratio declined in all 11 dogs (mean +/- SD pre: 0.24 +/- 0.14; post: 0.16 +/- 0.11; P < 0.05), but changes in the X/G ratio were more variable. These findings show that SIBO is commonly associated with mucosal damage not detected on histological examination of intestinal biopsies, and that changes in intestinal permeability following oral antibiotics may be used to monitor response to treatment.
Rutgers
H C
HC
Department of Small Animal Medicine and Surgery, Royal Veterinary College, North Mymms, Hertfordshire.
Batt
R M
RM
Proud
F J
FJ
Sørensen
S H
SH
Elwood
C M
CM
Petrie
G
G
Matthewman
L A
LA
Forster-van Hijfte
M A
MA
Boswood
A
A
Entwistle
M
M
Fensome
R H
RH
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy / Q000662:veterinary; D002167:Campylobacter / Q000302:isolation & purification; D002241:Carbohydrates / Q000493:pharmacokinetics*; D004283:Dog Diseases / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology*; D004285:Dogs; D005260:Female; D007410:Intestinal Diseases / Q000378:metabolism / Q000503:physiopathology / Q000662:veterinary*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D007421:Intestine, Small / Q000187:drug effects / Q000382:microbiology* / Q000502:physiology; D007422:Intestines / Q000473:pathology / Q000502:physiology*; D007792:Lactulose / Q000652:urine; D008297:Male; D010118:Oxytetracycline / Q000008:administration & dosage / Q000627:therapeutic use; D010539:Permeability; D012210:Rhamnose / Q000652:urine; D012475:Salmonella / Q000302:isolation & purification; D014994:Xylose / Q000652:urine
D000900:Anti-Bacterial Agents; D002241:Carbohydrates; D007792:Lactulose; D014994:Xylose; D012210:Rhamnose; D010118:Oxytetracycline